Edward Kim, MD, MBA

This study examines the association between cost-sharing and initiation of disease-modifying therapies among privately insured patients with multiple sclerosis.

Patients with inadequate response to depression treatment used increased resources, were less likely to be employed, and had more presenteeism than those with treatment response.

When a clinical staging algorithm for treatment-resistant depression was applied to administrative claims data, higher scores predicted higher future medical costs.